Illumina Ventures
North America, California, United States, Foster City
Description
Illumina Ventures visions is to improve human health by unlocking the power of the genome.
Investor Profile
Illumina Ventures has made 70 investments, with 5 in the past 12 months and 33% as lead.
Stage Focus
- Series A (29%)
- Series B (26%)
- Series C (13%)
- Series D (10%)
- Series Unknown (10%)
- Seed (9%)
- Series E (3%)
- Debt Financing (1%)
Country Focus
- United States (84%)
- France (11%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Life Science
- Genetics
- Health Diagnostics
- Therapeutics
- Pharmaceutical
- Medical Device
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
